September 26, 2024 – Envision Pharma Group

News and views:

September 26, 2024

New

From publications to evidence ecosystems

AI, Medical, Publications, Technology

Oct. 06, 2026

Eight priorities for future-ready publication leaders...

Connected evidence: from insight to impact

AI, Publications, Technology

Sep. 22, 2026

The future of scientific evidence and publications...

What actually moves the needle: measuring the value of patient advocacy

Patient Advocacy, Patient Engagement, Strategic Consulting

Sep. 01, 2026

Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth

Commercialization, Executive Leadership, Technology

Aug. 25, 2026

New role brings commercial growth and client experience together to support a more connected approach for Envision’s life sciences clients...

What actually moves the needle: Redefining patient advocacy impact measures

Medical, Patient Engagement, Strategic Consulting

Jul. 23, 2026

Sign up to receive the white paper and access the Adaptive Advocacy Impact Framework...

Envision Pharma Group wins at the 2026 Communiqué Awards, with recognition across four categories

Europe, Medical, Technology

Jul. 14, 2026

Novartis MPN and CML Leaders Programme 2025 honored for measurable impact on rare blood cancer care across the UK...

Whitepaper: Simulated advisory boards

AI, Executive Leadership, Strategic Consulting, Technology

Jul. 13, 2026

How to accelerate strategic decision-making in biopharma...